S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
S&P 500   2,713.16 (+1.86%)
DOW   23,189.40 (+2.25%)
QQQ   198.85 (+1.21%)
FB   169.21 (+2.21%)
MSFT   164.70 (-0.34%)
GOOGL   1,193.55 (+0.88%)
AMZN   2,012.01 (+0.72%)
CGC   14.94 (+4.18%)
NVDA   265.09 (-1.23%)
BABA   198.55 (+1.07%)
MU   46.47 (-0.41%)
T   30.34 (+3.06%)
GILD   73.97 (-4.84%)
DIS   102.75 (+3.18%)
PRI   89.73 (+2.87%)
Log in

NASDAQ:XLRNAcceleron Pharma SEC Filings & 10K Form

$86.54
-0.67 (-0.77 %)
(As of 04/7/2020 10:38 AM ET)
Add
Compare
Today's Range
$86.24
Now: $86.54
$89.78
50-Day Range
$70.82
MA: $85.20
$94.85
52-Week Range
$37.01
Now: $86.54
$97.56
Volume2,413 shs
Average Volume698,529 shs
Market Capitalization$4.62 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.91

SEC Filings

Acceleron Pharma (NASDAQ:XLRN) SEC Filings

DateFilerForm TypeView
04/06/2020
7:41 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2020
3:13 PM
Acceleron Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
3:10 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
8:26 AM
Acceleron Pharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/10/2020
5:01 PM
Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
Form 4/A
02/10/2020
4:50 PM
Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
Form 4/A
01/27/2020
3:14 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
6:32 PM
Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:59 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:48 PM
Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:45 PM
Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:41 PM
Acceleron Pharma (Issuer)
George Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:37 PM
Acceleron Pharma (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:33 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:27 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:21 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:18 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
3:20 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:36 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:51 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:48 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:45 PM
Acceleron Pharma (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:41 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:37 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:32 PM
Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:24 PM
Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:20 PM
Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2019
5:39 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
5:19 PM
Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2019
3:35 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
7:04 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
4:26 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
9:16 AM
Acceleron Pharma (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
11/08/2019
4:27 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
6:57 AM
Acceleron Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
6:54 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
4:12 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
7:25 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:24 PM
Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:23 PM
Acceleron Pharma (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:22 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:21 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:18 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:09 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
4:49 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
3:26 PM
Acceleron Pharma (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2019
8:51 AM
Acceleron Pharma (Filer)
Form CT ORDER
06/28/2019
6:25 PM
Acceleron Pharma (Issuer)
George Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:08 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:47 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
3:39 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:38 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/07/2019
3:06 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:09 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
3:22 PM
Acceleron Pharma (Filer)
Form DEFA14A
04/12/2019
3:20 PM
Acceleron Pharma (Filer)
Form DEF 14A
04/11/2019
3:58 PM
Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:58 PM
Acceleron Pharma (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:58 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:58 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2019
4:19 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
5:07 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:28 PM
Acceleron Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2019
3:12 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
12:50 PM
Acceleron Pharma (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
01/29/2019
4:50 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:49 PM
Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:48 PM
Acceleron Pharma (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:47 PM
Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:47 PM
Acceleron Pharma (Issuer)
Maniatis Tom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:46 PM
Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:45 PM
Acceleron Pharma (Issuer)
George Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:44 PM
Acceleron Pharma (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:43 PM
Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:42 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:41 PM
Acceleron Pharma (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:40 PM
Acceleron Pharma (Issuer)
Zeldin Robert K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:38 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:37 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
4:00 PM
Acceleron Pharma (Subject)
CELGENE CORP /DE/ (Filed by)
Form SC 13D/A
01/22/2019
4:00 PM
Acceleron Pharma (Issuer)
CELGENE CORP /DE/ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
3:44 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2019
3:43 PM
Acceleron Pharma (Filer)
Form 424B2
01/14/2019
4:29 PM
Acceleron Pharma (Filer)
Form 424B5
01/07/2019
6:17 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
5:36 PM
Acceleron Pharma (Issuer)
Kumar Ravindra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
5:35 PM
Acceleron Pharma (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
5:34 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
5:34 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
3:22 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
7:34 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:13 PM
Acceleron Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2018
3:10 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2018
10:36 AM
Acceleron Pharma (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
08/31/2018
6:00 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:22 PM
Acceleron Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2018
3:30 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2018
4:01 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2018
3:47 PM
Acceleron Pharma (Issuer)
Zeldin Robert K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2018
3:44 PM
Acceleron Pharma (Issuer)
Zeldin Robert K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel